Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Oncology|March 22, 2012
HER2/neu may not be an interesting target in biliary cancers: results of an early phase II study with lapatinibJoshua Peck, Lai Wei, Mark Zalupski, et al.Journal of Cachexia, Sarcopenia and Muscle|July 7, 2018
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancerJoshua K Kays, Safi Shahda, Melissa Stanley, et al.Cancers|December 18, 2020
Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery PlatformAshok Narasimhan, Safi Shahda, Joshua K Kays, et al.The Oncologist|August 18, 2018
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid TumorsGregory L Beatty, Safi Shahda, Thaddeus Beck, et al.Investigational New Drugs|July 25, 2019
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancerS Lindsey Davis, Dana B Cardin, Safi Shahda, et al.Gastrointestinal Cancer Research : GCR|May 23, 2009
A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or HigherUsman Shah, Bert O'Neil, Jill Allen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 13, 2018
Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 TrialAllen Cohn, Michael A Morse, Bert O'Neil, et al.The American Journal of Gastroenterology|February 1, 2017
A Multidisciplinary Approach to Pancreas Cancer in 2016: A ReviewEvan L Fogel, Safi Shahda, Kumar Sandrasegaran, et al.Molecular Cancer Therapeutics|August 19, 2016
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer ModelsDerek P Logsdon, Michelle Grimard, Meihua Luo, et al.Investigational New Drugs|October 16, 2009
Phase I trial of vinflunine and pemetrexed in refractory solid tumorsHanna K Sanoff, Janine Davies, Christine Walko, et al.Pageof 7